Alphatec Holdings (ATEC) Reports Robust 2024 Financial Results and Projects Strong Growth for 2025
CARLSBAD, Calif., January 13, 2025 — Alphatec Holdings, Inc. (Nasdaq: ATEC), a leader in innovative spine surgery solutions, announced preliminary financial results for the fiscal year ended December 31, 2024, and provided its financial outlook for 2025.
2024 Financial Highlights
- Total Revenue: Approximately $611 million, representing a 27% increase year-over-year.
- Surgical Revenue: Grew by 29% to approximately $544 million, driven by a 19% increase in surgical volume and an 8% rise in average revenue per procedure.
- EOS Revenue: Estimated between $66.7 million and $67.2 million.
- Cash Balance: Approximately $139 million as of December 31, 2024, up $58 million from the third quarter, including $50 million from a term loan expansion.
CEO Pat Miles commented, “Our dedication to revolutionizing spine surgery fueled another year of sector-leading growth and an inflection to profitability in 2024.”
2025 Outlook
- Projected Total Revenue: Approximately $732 million, indicating a 20% increase over 2024.
- Surgical Revenue: Expected to be around $657 million.
- EOS Revenue: Anticipated to reach approximately $75 million.
- Adjusted EBITDA: Projected at approximately $75 million, contributing to positive free cash flow for the year.
The company plans to report its fourth-quarter and full-year 2024 financial results on February 26, 2025, after market close, with a live webcast scheduled at 1:30 p.m. PT / 4:30 p.m. ET.
Alphatec Holdings continues to focus on delivering innovative spine surgery solutions, with a strong emphasis on surgeon adoption and procedural innovation, positioning the company for sustained growth in 2025 and beyond.
